We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Molecular Target Identified for Treating Deadly Lung Disease

News   Apr 11, 2018 | Original story from Cincinnati Children’s Hospital

 
Molecular Target Identified for Treating Deadly Lung Disease

In this microscopic photo of tissue from mouse lung with idiopathic pulmonary fibrosis (IPF), extensive fibrosis and collagen deposits (shown in red) have extensively infiltrated the tissue. Researchers at Cincinnati Children's report in Cell Reports that loss of the gene Foxf1 in lung myofibroblasts increased the severity of IPF in mice. Credit: Cincinnati Children's

 
 
 

RELATED ARTICLES

The Key to a Good Night’s Sleep?

News

A team of researchers has now created 3D maps of MT1 and MT2 melatonin receptors revealing the structural basis of the selectivity of each receptor subtype. They intend to use this structural information to design drug molecules that better target and bind to each of the two receptors.

READ MORE

Kicking the Habit: Effectiveness of Different Forms of Nicotine Replacement Therapy

News

New evidence published in the Cochrane Library provides high quality evidence that people who use a combination of nicotine replacement therapies (a patch plus a short acting form, such as gum or lozenge) are more likely to successfully quit smoking than people who use a single form of the medicine.

READ MORE

Blood Test Indicates Alzheimer's Drug Effect on Nerve Cell Loss

News

A new study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in the brain. The researchers analysed neurofilament light protein in blood samples from patients with Alzheimer’s disease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE